Automated Patch Clamp Recordings of Human Stem Cell-Derived Cardiomyocytes

[1]  Charles H Large,et al.  Automated patch clamping using the QPatch. , 2009, Methods in molecular biology.

[2]  N. Klugbauer,et al.  Structure and functional expression of a new member of the tetrodotoxin‐sensitive voltage‐activated sodium channel family from human neuroendocrine cells. , 1995, The EMBO journal.

[3]  A. V. van Ginneken,et al.  Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1 , 2015, Front. Physiol..

[4]  B. Sakmann,et al.  Single-channel currents recorded from membrane of denervated frog muscle fibres , 1976, Nature.

[5]  T. Colatsky,et al.  A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm , 2016, Journal of biomolecular screening.

[6]  Michael George,et al.  Port-a-patch and patchliner: high fidelity electrophysiology for secondary screening and safety pharmacology. , 2009, Combinatorial chemistry & high throughput screening.

[7]  Andrea Brüggemann,et al.  Novel screening techniques for ion channel targeting drugs , 2015, Channels.

[8]  Xuebin B. Yang,et al.  Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes , 2016, Stem cells and development.

[9]  Huimin Tao,et al.  Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. , 2004, Assay and drug development technologies.

[10]  N. Fertig,et al.  Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system. , 2013, Journal of pharmacological and toxicological methods.

[11]  D. Rothwarf,et al.  A benchmark study with sealchip planar patch-clamp technology. , 2003, Assay and drug development technologies.

[12]  Icilio Cavero,et al.  Comprehensive in vitro Proarrhythmia Assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiative , 2014, Expert opinion on drug safety.

[13]  Thomas Knott,et al.  Introduction of a modular automated voltage-clamp platform and its correlation with manual human Ether-à-go-go related gene voltage-clamp data. , 2011, Assay and drug development technologies.

[14]  R. Kass,et al.  Negative surface charge density near heart calcium channels. Relevance to block by dihydropyridines , 1987, The Journal of general physiology.

[15]  Mohamed Chahine,et al.  New Insights into Cardiac and Brain Sodium Channels Modulation by Beta Blockers , 2011, Front. Pharmacol..

[16]  A Brüggemann,et al.  High quality ion channel analysis on a chip with the NPC technology. , 2003, Assay and drug development technologies.

[17]  N. Fertig,et al.  Automated Patch Clamp Analysis of nAChα7 and NaV1.7 Channels , 2014, Current protocols in pharmacology.

[18]  Sonja Stoelzle,et al.  Microchip technology for automated and parallel patch-clamp recording. , 2006, Small.

[19]  D. Hanck,et al.  Gating of skeletal and cardiac muscle sodium channels in mammalian cells , 1999, The Journal of physiology.

[20]  Michael George,et al.  Automated Patch Clamp Meets High-Throughput Screening , 2016, Journal of laboratory automation.

[21]  N. Fertig,et al.  Ion channel drug discovery and research: the automated Nano-Patch-Clamp technology. , 2004, Current drug discovery technologies.

[22]  Arthur M. Brown,et al.  Evaluating State Dependence and Subtype Selectivity of Calcium Channel Modulators in Automated Electrophysiology Assays , 2014, Assay and drug development technologies.

[23]  A. Pappano,et al.  Comparison of L-type calcium channel blockade by nifedipine and/or cadmium in guinea pig ventricular myocytes. , 2000, The Journal of pharmacology and experimental therapeutics.

[24]  T. Snutch,et al.  Calcium currents recorded from a neuronal α1C L‐type calcium channel in Xenopus oocytes , 1994 .

[25]  R. Peri,et al.  High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology , 2008, Nature Reviews Drug Discovery.

[26]  Steven J Novick,et al.  Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG. , 2013, Journal of pharmacological and toxicological methods.

[27]  Yi Liu,et al.  QPatch: the missing link between HTS and ion channel drug discovery. , 2009, Combinatorial chemistry & high throughput screening.

[28]  Cristian Ionescu-Zanetti,et al.  Ion channel pharmacology under flow: automation via well-plate microfluidics. , 2012, Assay and drug development technologies.

[29]  Michael George,et al.  Characterizing Human Ion Channels in Induced Pluripotent Stem Cell–Derived Neurons , 2012, Journal of biomolecular screening.

[30]  Derek J Trezise,et al.  IonWorks™ HT: A New High-Throughput Electrophysiology Measurement Platform , 2003, Journal of biomolecular screening.

[31]  Ralf Kettenhofen,et al.  Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system. , 2013, Journal of pharmacological and toxicological methods.

[32]  Gary Gintant,et al.  Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. , 2014, American heart journal.

[33]  Alan Finkel,et al.  Population Patch Clamp Improves Data Consistency and Success Rates in the Measurement of Ionic Currents , 2006, Journal of biomolecular screening.

[34]  Ralf Kettenhofen,et al.  State-of-the-Art Automated Patch Clamp Devices: Heat Activation, Action Potentials, and High Throughput in Ion Channel Screening , 2011, Front. Pharmacol..